Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Xenon

EU orphan designation number: EU/3/16/1768   
Active ingredient: Xenon
Indication: Treatment of ischaemia reperfusion injury associated with cardiac arrest
Sponsor: Neuroprotexeon Ltd
52 Princes Gate, Exhibition Road, London SW7 2PG, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/109/16 (2016)6760 of 14/10/2016